Post-COVID-19: effects on mental health and metabolic markers in type 2 diabetes.

Q2 Medicine
Medicine and Pharmacy Reports Pub Date : 2026-01-01 Epub Date: 2026-01-30 DOI:10.15386/mpr-2911
Alecsandra-Andreea Budihoi, Violeta Briciu, Mihaela Lupse, Mihaela Gribovschi, Bogdana Nasui, Nina Ciuciuc, Tudor Calinici, Monica Popa
{"title":"Post-COVID-19: effects on mental health and metabolic markers in type 2 diabetes.","authors":"Alecsandra-Andreea Budihoi, Violeta Briciu, Mihaela Lupse, Mihaela Gribovschi, Bogdana Nasui, Nina Ciuciuc, Tudor Calinici, Monica Popa","doi":"10.15386/mpr-2911","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aims to assess the impact of COVID-19 infection on both mental well-being and biological parameters of patients with type 2 diabetes, highlighting the potential long-term effects.</p><p><strong>Methods: </strong>A longitudinal observational study was conducted on a total of 62 patients diagnosed with type 2 diabetes. We used two validated questionnaires: the WHO-5 Well-Being Index (WHO-5) and the Diabetes Distress Scale (DDS). Biological data were extracted from medical records. We had two-point evaluations, in 2023 and 2024. Patients were divided into three groups based on the year of COVID-19 diagnosis: 2020, 2021, 2022. Descriptive and inferential statistics were performed, with results presented as percentages and associations. The Wilcoxon signed-rank test, the Kruskal-Wali's test, and Spearman's rank correlation coefficient (ρ) were applied for non-normally distributed variables. Analyses were performed using Jamovi 3.2.28. A p value < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>There were 24 (38.7%) females, and 38 (61.3%) males. The mean age was 66.5 years. From the medical history, regarding COVID-19 severity, 7 (11.3%) of cases were classified as mild 29 (46.8%) as moderate, and 26 (41.9%) as severe. WHO-5 scores increased from a mean of 42.5 from 2023 to 51.2 in 2024, indicating improved psychological well-being over time. A significant reduction in diabetes-related emotional distress was observed (p < 0.001). Regimen-related distress scores showed a small but significant decrease from 2023 to 2024 (p = 0.004). A statistically significant correlation was observed between WHO-5 score (2023) and LDL cholesterol (2024) (ρ = 0.629, p = 0.02). Descriptive statistics showed that mean HDL cholesterol values vary with COVID-19 severity levels.</p><p><strong>Conclusion: </strong>Psychological well-being showed an improvement over time. Emotional distress related to diabetes, including emotional burden and regimen-related distress decreased with time. Serum LDL- and HDL cholesterol levels may play a potential role in supporting psychological well-being. This study reinforces the importance of holistic approaches in managing post-COVID-19 effects, especially in patients with pre-existing metabolic disorders.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"99 1","pages":"49-56"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13008018/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine and Pharmacy Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15386/mpr-2911","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study aims to assess the impact of COVID-19 infection on both mental well-being and biological parameters of patients with type 2 diabetes, highlighting the potential long-term effects.

Methods: A longitudinal observational study was conducted on a total of 62 patients diagnosed with type 2 diabetes. We used two validated questionnaires: the WHO-5 Well-Being Index (WHO-5) and the Diabetes Distress Scale (DDS). Biological data were extracted from medical records. We had two-point evaluations, in 2023 and 2024. Patients were divided into three groups based on the year of COVID-19 diagnosis: 2020, 2021, 2022. Descriptive and inferential statistics were performed, with results presented as percentages and associations. The Wilcoxon signed-rank test, the Kruskal-Wali's test, and Spearman's rank correlation coefficient (ρ) were applied for non-normally distributed variables. Analyses were performed using Jamovi 3.2.28. A p value < 0.05 was considered statistically significant.

Results: There were 24 (38.7%) females, and 38 (61.3%) males. The mean age was 66.5 years. From the medical history, regarding COVID-19 severity, 7 (11.3%) of cases were classified as mild 29 (46.8%) as moderate, and 26 (41.9%) as severe. WHO-5 scores increased from a mean of 42.5 from 2023 to 51.2 in 2024, indicating improved psychological well-being over time. A significant reduction in diabetes-related emotional distress was observed (p < 0.001). Regimen-related distress scores showed a small but significant decrease from 2023 to 2024 (p = 0.004). A statistically significant correlation was observed between WHO-5 score (2023) and LDL cholesterol (2024) (ρ = 0.629, p = 0.02). Descriptive statistics showed that mean HDL cholesterol values vary with COVID-19 severity levels.

Conclusion: Psychological well-being showed an improvement over time. Emotional distress related to diabetes, including emotional burden and regimen-related distress decreased with time. Serum LDL- and HDL cholesterol levels may play a potential role in supporting psychological well-being. This study reinforces the importance of holistic approaches in managing post-COVID-19 effects, especially in patients with pre-existing metabolic disorders.

Abstract Image

Abstract Image

Abstract Image

covid -19后:对2型糖尿病患者心理健康和代谢标志物的影响
背景:本研究旨在评估COVID-19感染对2型糖尿病患者心理健康和生物学参数的影响,并强调潜在的长期影响。方法:对62例诊断为2型糖尿病的患者进行纵向观察研究。我们使用了两份有效的问卷:WHO-5幸福指数(WHO-5)和糖尿病困扰量表(DDS)。从医疗记录中提取生物学数据。我们在2023年和2024年进行了两点评估。根据确诊年份将患者分为三组:2020年、2021年、2022年。进行描述性和推断性统计,结果显示为百分比和关联。对非正态分布变量采用Wilcoxon符号秩检验、Kruskal-Wali检验和Spearman秩相关系数(ρ)。采用Jamovi 3.2.28进行分析。p值< 0.05认为有统计学意义。结果:女性24例(38.7%),男性38例(61.3%)。平均年龄为66.5岁。从病史来看,在严重程度上,轻度7例(11.3%),中度29例(46.8%),重度26例(41.9%)。世卫组织-5得分从2023年的平均42.5分增加到2024年的51.2分,表明随着时间的推移,心理健康状况有所改善。观察到糖尿病相关的情绪困扰显著减少(p < 0.001)。从2023年到2024年,与治疗方案相关的痛苦评分出现了小幅但显著的下降(p = 0.004)。WHO-5评分(2023)与LDL -胆固醇(2024)有统计学意义(ρ = 0.629, p = 0.02)。描述性统计显示,平均HDL胆固醇值随COVID-19严重程度的不同而变化。结论:随着时间的推移,心理健康状况有所改善。与糖尿病相关的情绪困扰,包括情绪负担和治疗方案相关的困扰,随着时间的推移而减少。血清低密度脂蛋白和高密度脂蛋白胆固醇水平可能在支持心理健康方面发挥潜在作用。这项研究强调了整体方法在管理covid -19后影响方面的重要性,特别是对于已经存在代谢紊乱的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicine and Pharmacy Reports
Medicine and Pharmacy Reports Medicine-Medicine (all)
CiteScore
3.10
自引率
0.00%
发文量
63
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书